Responses
Basic tumor immunology
Original research
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
Compose a Response to This Article
Other responses
No responses have been published for this article.